VIENNA, Va., Oct. 11 /PRNewswire-FirstCall/ -- CEL-SCI Corp. (Amex: CVM) announces the following Webcast:
What: | Biotech, Healthcare and Pharma Virtual Conference | |
When: | October 13, 2010 @ 11:30 AM Eastern | |
Where: | http://www.investorcalendar.com/ClientPage.asp?ID=161779 | |
How: | Live over the Internet -- Simply log on to the web at the address above. | |
Contact: | Kelley Kulick, 804-327-3433, kkulick@precisionir.com | |
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=161779 or http://www.investorcalendar.com/
CEL-SCI has a first line head & neck cancer product, Multikine, cleared for Phase III testing world-wide. Phase II studies showed the product to be safe and give a 33% increase in overall survival 42 months after surgery. Other work is ongoing with a product that stimulates the innate immunity for the treatment/vaccination of several diseases.
SOURCE CEL-SCI Corp.
